Results

Total Results: 165 records

Showing results for "bone density".
Users also searched for: dexa

61. Archived: Final Evidence Summary: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    December 10, 2011 - calcium , and text terms and Medical Subject Heading terms related to cancer or neoplasms, fracture, and bone … mineral density. … Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older … Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes … The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked

62. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
    May 29, 2012 - mineral density) and emphasizes medications, health care settings, and populations of postmenopausal … mineral density, or fracture risk score in the WHI trial 17 . … Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative … Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. … mineral density Fractures, cognitive function, and urinary incontinence WISDOM 62 CEE, 0.625

63. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
    May 09, 2005 - density to prevent fractures. … The role of chemopreventive agents in preventing fractures in women without low bone density is unclear … density and reduces the risk for fractures. … Overall, a good-quality body of evidence supports the efficacy of hormone therapy in increasing bone … density and decreasing fracture risk.

64. Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
    May 01, 2005 - density to prevent fractures. … The role of chemopreventive agents in preventing fractures in women without low bone density is unclear … density and reduces the risk for fractures. … Overall, a good-quality body of evidence supports the efficacy of hormone therapy in increasing bone … density and decreasing fracture risk.

65. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
    May 09, 2005 - density to prevent fractures. … The role of chemopreventive agents in preventing fractures in women without low bone density is unclear … density and reduces the risk for fractures. … Overall, a good-quality body of evidence supports the efficacy of hormone therapy in increasing bone … density and decreasing fracture risk.

66. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
    October 22, 2015 - outcomes of chronic conditions associated with hormone therapy (e.g., intermediate outcomes, such as bone … density and cholesterol level) Duration of intervention ≥1 year of treatment <1 year of treatment

67. Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/U4Vu9hcmHtD7snox6qbPja
    June 21, 2022 - 50, 58-60, 62-64, 66-69, 72, 73, 75, 76, 78, 82, 83, 86-90 Most of the studies had aims related to bone … density, fractures, or falls and were primarily limited to adults 55 years or older. … density, fractures, or falls Supplement use in cohort studies was self-reported Kidney stones: low … Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older … Vitamin D supplementation and bone mineral density in early postmenopausal women.

68. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the USPSTF Recommendations (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
    July 01, 2012 - mineral density) and emphasizes medications, health care settings, and pop- ulations of postmenopausal … mineral density, clinical fractures, endometrial hyperplasia, urinary inconti- nence, and cognitive … mineral density, or fracture risk score in the WHI trial (17). … Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative … Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.

69. Screening for Celiac Disease: Literature Surveillance Report (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z7HXw3FPGLPFrcJoKq6ZeK
    May 01, 2022 - on hypoglycemic episodes, HbA1c, height (in pediatric participants), weight, serum nutrient levels, bone … mineral content and density after one year.10 The CD-DIET reports on adherence, TTG IgA, generic and

70. Draft Research Plan: Menopausal Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-women-primary-prevention-chronic-conditions
    February 18, 2021 - Diabetes Any outcomes that are not health outcomes of chronic conditions associated with HT; such as bone … density and cholesterol level Duration of intervention 1 year of treatment Less than 1 year

71. Draft Research Plan: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
    February 18, 2021 - Diabetes Any outcomes that are not health outcomes of chronic conditions associated with HT; such as bone … density and cholesterol level Duration of intervention 1 year of treatment Less than 1 year

72. Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions: A Summary of the Evidence for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
    October 01, 2002 - Low bone density? 7. Fractures? 8. Decline in cognitive function? 9. Dementia? … density outcomes, RCTs consistently indicated improved bone density with estrogen use. … Use of usual doses (eg, 0.625 mg of conjugated estrogen) resulted in greater bone density increases at … density and prior fractures. … Low bone density?

73. Final Research Plan: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan37/vitamin-d-deficiency-screening
    March 24, 2014 - is the effect of vitamin D (with or without calcium) on intermediate outcomes (e.g., blood pressure, bone … mineral density, glucose tolerance, and lipid levels)?

74. Archived: Final Research Plan: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan37/vitamin-d-deficiency-screening-november-2014
    March 24, 2014 - is the effect of vitamin D (with or without calcium) on intermediate outcomes (e.g., blood pressure, bone … mineral density, glucose tolerance, and lipid levels)?

75. Archived: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    February 15, 2013 - maintain calcium homeostasis between the blood and bones, and is essential for bone growth and maintaining bone … density.

76. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate

77. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate

78. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
    August 21, 2002 - density outcomes, RCTs consistently indicated improved bone density with estrogen use. … Use of usual doses (e.g., 0.625 mg of conjugated estrogen) resulted in greater bone density increases … density and prior fractures. … Low bone density? Fractures? Decline in cognitive function? Dementia? … Low bone density?

79. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
    August 21, 2002 - density outcomes, RCTs consistently indicated improved bone density with estrogen use. … Use of usual doses (e.g., 0.625 mg of conjugated estrogen) resulted in greater bone density increases … density and prior fractures. … Low bone density? Fractures? Decline in cognitive function? Dementia? … Low bone density?

80. Fan-Qvpdgnjh8Krdf4Smmv (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/FaN-QvpDgnJh8KrdF4smmv
    May 01, 2013 - calcium homeostasis between the blood and bones, and is essential for bone growth and maintaining bone … density.